Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daniel K. Levy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Serum uric acid and cardiovascular disease risk [1] (multiple letters)
Alderman, M. H., Poulis, M., Culleton, B. F., Larson, M. G. & Levy, D., Apr 4 2000, In: Annals of internal medicine. 132, 7, p. 591-592 2 p.Research output: Contribution to journal › Letter › peer-review
6 Scopus citations -
Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
Kukin, M. L., Kalman, J., Charney, R. H., Levy, D. K., Buchholz-Varley, C., Ocampo, O. N. & Eng, C., May 25 1999, In: Circulation. 99, 20, p. 2645-2651 7 p.Research output: Contribution to journal › Article › peer-review
256 Scopus citations -
Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failure
Patel, M. B., Kaplan, I. V., Patni, R. N., Levy, D., Strom, J. A., Shirani, J. & LeJemtel, T. H., Jan 5 1999, In: Circulation. 99, 1, p. 60-64 5 p.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
Association of height and risk of myocardial infarction in women [2]
Safar, M. E., London, G. M., Levy, D., Larson, M. G. & Kannam, J. P., 1995, In: Circulation. 91, 11, p. 2853-2854 2 p.Research output: Contribution to journal › Letter › peer-review
4 Scopus citations -
Ischemic Hepatitis in a Patient with Congestive Cardiomyopathy: An Innovative Approach to Therapy Using Intravenous Dobutamine
Levy, D. K., Schwartz, J. M., Frishman, W. H., Schwarz, M. L. & LeJemtel, T. H., Mar 1994, In: The Journal of Clinical Pharmacology. 34, 3, p. 270-272 3 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations